Price $243.15 |
Market Cap
9.83B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
24.6
|
P/B
2.35
|
P/S
3.35
|
Dividend %
0.60%
|
|
P/CF
-
|
P/FCF
38.3
|
Op. Cash Flow
410.7K
|
FCF
5.5
|
|
Op. Margin
17.50%
|
Net Margin
12.50%
|
ROE
9.10%
|
ROI
7.30%
|
|
ROA
5.40%
|
EPS Growth
-27.90%
|
Current Ratio
2.4
|
Debt/Equity
40.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chromadex Corp (CDXC) | $3.26 | - | - | 105.8M | Strong Buy |
| iCAD Inc (ICAD) | $1.51 | - | - | 38.2M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.40 | - | - | 14.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.73 | - | - | 183.6M | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
